Ravi Lokesh

7PUBLICATIONS
53CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesNeurology and neuromuscular diseasesIndustrial microbiology (incl. biofeedstocks)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 14, 2025
"Heptadecanol" a phytochemical multi-target inhibitor of SMYD3 & GFPT2 proteins in non-small cell lung cancer: an in-silico & in-vitro investigation.

Lokesh Ravi, Pratishtha Jain, Ajith Kumar K

|Sep 12, 2024
In silico analysis reveals α-amylase inhibitory potential of Taraxerol (Coccinia indica) and Epoxywithanolide-1 (Withania coagulans): a possible way to control postprandial hyperglycemia-induced endothelial dysfunction and cardiovascular events.

Lokesh Ravi, Venkatesh Sadhana, Pratishtha Jain

|Apr 16, 2024
Molecular dynamic investigation for Roco4 kinase inhibitor as treatment options for parkinsonism.

Kankana Dutta, Lokesh Ravi

|Feb 14, 2024
Behenic Acid as a multi-target inhibiting antibacterial phytochemical against Vibrio parahaemolyticus and Aeromonas hydrophila for effective management of aquaculture infections: an in-silico, in-vitro & in-vivo experimentation.

Lokesh Ravi, Ajith Kumar K, Shree Kumari G R

|Sep 11, 2023
Stearyl palmitate a multi-target inhibitor against breast cancer: in-silico, in-vitro & in-vivo approach.

Lokesh Ravi, Ajith Kumar K, Shree Kumari G R

|Mar 07, 2023
β-Sitosterol, a phytocompound from Parthenium hysterophorus, reveals anti-diabetic properties through α-Amylase inhibition: an in-silico and in-vitro analysis.

Lokesh Ravi, Shabari Girish, Sharun Roy D'Souza

Pageof 2

Frequent Collaborators

5 joint publications

Ajith Kumar Krishnan

4 joint publications

Shree Kumari Gr

2 joint publications

Mookkandi Palsamy Kesavan

2 joint publications

Mohanasrinivasan Vaithilingam